Thursday, October 17, 2019

Plexium Picks Up $28M For Cancer, Neurogenerative Disease Efforts

San Diego-based Plexium, which is developing E3 ligase-modulating therapeutics to treat cancer and neurodegenerative diseases, has raised $28 in a Series A funding round, the company announced on Thursday morning. The funding was led by DCVC Bio and The Column Group, and also included M Ventures, CRV, and Neotribe Ventures. The company is led by founder

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.